May 2010 Volume 6, Issue 5

Volume 6, Issue 5 | May 2010

May 2010

In this Issue

Omics & Systems Biology

Drug Discovery News Placeholder Image

Common sense

GSK strikes $1.5 billion-plus deal to use Isis’ antisense platform for development of rare disease therapeutics
Drug Discovery News Placeholder Image

Making siRNA research a SNALP

Tekmira to use stable nucleic acid-lipid particle technology to deliver Pfizer’s siRNA molecules
Drug Discovery News Placeholder Image

Gene silencing takes steps forward

Dicerna Pharmaceuticals and Ipsen to collaborate on therapeutic agents in endocrinology and oncology
Drug Discovery News Placeholder Image

Building a better mousetrap

Affymetrix and Jackson Laboratory announce the official commercial launch of groundbreaking mouse diversity genotyping array
Drug Discovery News Placeholder Image

Getting the bugs out of the flu

Emory University School of Medicine and Zirus team up to create new class of antiviral drugs

Global News

Drug Discovery News Placeholder Image

An ironclad partnership

AMAG and Takeda announce strategic collaboration for iron deficiency anemia drug Feraheme
Drug Discovery News Placeholder Image

sanofi-aventis inks diabetes test agreement with AgaMatrix

Companies to develop and market blood glucose marketing tests
Drug Discovery News Placeholder Image

Banking on personalized medicine

Life Technologies and the Integrated Biobank of Luxembourg to sequence biospecimen samples for advancement of disease research
Drug Discovery News Placeholder Image

Expanding its footprint

AstraZeneca extends branded generics capability with Torrent agreement
Drug Discovery News Placeholder Image

Expressing themselves

Eden Biodesign brings its cGMP manufacturing expertise together with Millipore’s UCOE express technology

Government Watch

Drug Discovery News Placeholder Image

Patent wars persist

Myriad poised to appeal court ruling invalidating patents on breast cancer genes
Drug Discovery News Placeholder Image

Winners and losers in healthcare reform

New legislation has pros and cons for pharmaceutical industry
Drug Discovery News Placeholder Image

Southern comfort

Maine-based Jackson Laboratory may soon be in the position of opening a new facility in Florida
Drug Discovery News Placeholder Image

Genomics research takes hit in Minnesota

State-wide budget cuts mean less funding for Minnesota Partnership for Biotechnology and Medical Genomics

Special Reports

Drug Discovery News Placeholder Image

SPECIAL REPORT: Outsourcing under the microscope

As some companies tighten their belts, CROs across the globe are enjoying this growing business trend

Diagnostics

Drug Discovery News Placeholder Image

Signed, sealed, delivered

PerkinElmer acquires diagnostic genetic testing firm Signature Genomics
Drug Discovery News Placeholder Image

Partnership is air for the lungs

Source BioScience inks deal with AstraZeneca to provide genetic testing service for lung cancer
Drug Discovery News Placeholder Image

Companies Seeq infectious disease answers

Novartis to market Smiths Detection’s Bio-Seeq instrument and technology for infectious disease diagnostics
Drug Discovery News Placeholder Image

Best served at room temperature: Just add water

GenVault provides GenTegra DNA to support cardio genetic testing at Berkeley HeartLab
Drug Discovery News Placeholder Image

Optimizing breast cancer therapy strategies

Health Discovery and Smart Personalized Medicine to develop technology for lab tests aimed at personalized breast cancer therapy

Editor's Focus

Drug Discovery News Placeholder Image

Autism story hits close to home for ddn reporter

The discoveries, technologies and advances involved in the deals our editors and reporters write about each month sometimes hit very close to home.

Patent News

Drug Discovery News Placeholder Image

The Patent Reform Act of 2010: A substitute S. 515

Here comes the Patent Reform Act of 2010 in the form of an amendment to S. 515.

Commentary

Drug Discovery News Placeholder Image

What drug discoverers should know about interferon and its future

A deeper understanding of interferons’ varied functions within the immune system may lead to discovery of more effective therapies

Instruments & Informatics

Drug Discovery News Placeholder Image

Deal is cut and dried

Luminex acquires automation firm BSD Robotics, expanding expertise in field of dry sample handling
Drug Discovery News Placeholder Image

Transcending clinical trial hurdles

Acquisition of TranSenda adds clinical trial management software to BioClinica’s portfolio
Drug Discovery News Placeholder Image

Quality model + quality data = 250,000 molecules/hour

Symyx partners with Simulations Plus to improve predictive modeling of metabolites and metabolic pathways
Drug Discovery News Placeholder Image

A good fit for sequencing

CLC bio partners with Ion Torrent to expand high-throughput sequencing support

Research & Development

Drug Discovery News Placeholder Image

Resistance is futile

NeurOp and Bristol-Myers Squibb to develop NeurOp’s NMDAR antagonists in treatment-resistant depression
Drug Discovery News Placeholder Image

Cancer research turns a corner

NCI taps Cornerstone Pharmaceuticals’ nanotechnology for evaluation of anti-cancer agents
Drug Discovery News Placeholder Image

Allies against autism

Rett Syndrome Research Trust, Melior Discovery to develop drug candidates for most disabling form of autism
Drug Discovery News Placeholder Image

Giving a lymph to patients

Moffitt Cancer Center receives NCI grant to create bioengineered “designer” lymph nodes with Scripps Florida

New Products

Drug Discovery News Placeholder Image

Plate-based, label-free biosensor

SRU Biosystems recently announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND Scanner, a plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.

Feature

Drug Discovery News Placeholder Image

Small organisms in the big city

Pharma and surfing mecca San Diego plays host to this year’s ASM meeting
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue